RGMB and lung adenocarcinoma: The results indicated that silencing of lncRNA RGMB-AS1 and RGMB overexpression have the similar effect on A549 and SPC-A-1 cells, which suggested that lncRNA RGMB-AS1 and RGMB is the valuable target for lung adenocarcinoma therapy.